GENEVA, Nov. 6 -- CAS CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECHNOLOGY, CHINESE ACADEMY OF SCIENCES filed a patent application (CN2025/092373) for “USE OF BAZ2B TARGET IN REVERSING MASH FIBROSIS”. With publication no. WO/2026/227400, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 45/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....